Author Archives: admin


Cambridge team probes COVID-19 impact on the heart – Business Weekly

University of Cambridge researchers are leveraging stem cell heart-in-a-dish technology to study the effects of coronavirus on the critical organ.

The technology was originally devised to explore potential treatments for heart failure. Now the British Heart Foundation is funding the team to help understand how and why COVID-19 impacts the heart.

Dr Sanjay Sinha and his team will exploit their expertise in growing 2D and 3D heart tissue in the laboratory from human stem cells to study how the coronavirus attaches to heart muscle cells and how it affects their ability to contract and relax.

By understanding how COVID-19 may impair heart function, the team will then be able to investigate potential protective treatments.

Dr Sinha is also exploring whether the immune response from COVID-19 is responsible for damaging the heart. Molecules called cytokines are part of the immune system and when theyre in high amounts they can cause inflammation. COVID-19 has been associated with a cytokine storm which can damage cells in the body.

To investigate this immune response on the heart, the team are obtaining blood samples from people with COVID-19 at a hospital in Cambridge.

The blood serum which contains the cytokines will be added onto their lab-grown 2D and 3D heart muscle cells to see if there is anything in the infected blood that has a toxic effect on the heart.

Dr Sinha said: Through harnessing our existing heart-in-a-dish techniques were in a prime position to investigate how and why COVID-19 can have such a devastating impact on the heart.

This new understanding should provide us with a test bed for screening drugs to protect the hearts of people with COVID-19.

Professor Metin Avkiran, BHFs Associate Medical Director, added: Were committed to supporting the fight against COVID-19. Many of our researchers, like Dr Sinha at the BHF Centre of Research Excellence in Cambridge, are applying their expertise to understanding the harmful and potentially deadly relationship between COVID-19 and the cardiovascular system.

With increasing evidence that people with severe COVID-19 may suffer heart damage it is vital to understand if, and how, the coronavirus attacks heart muscle as a first step to finding new treatments.

Pioneering research such as this could inform how we care for people who develop COVID-19 when theyre unwell and in their long-term recovery.

View original post here:
Cambridge team probes COVID-19 impact on the heart - Business Weekly

Impact of COVID-19 on Stem Cell Assay Market To Experience Significant Growth During The Forecast Period 2020-2027 | By Top Key Players Merck &…

Notice:This Content doesnt contains all the Information of the Report please fill the form (via link) and get all interesting information just one click in PDF with latest update with chart and Table of Content

The report offers a systematic presentation of the existing trends, growth opportunities, market dynamics that are expected to shape the growth of the Stem Cell Assay market. The various research methods and tools were involved in the market analysis, to uncover crucial information about the market such as current & future trends, opportunities, business strategies and more, which in turn will aid the business decision-makers to make the right decision in future.

This Report Covers Leading Companies Associated in Worldwide Stem Cell Assay Market: Merck & Co., Thermo Fisher Scientific, GE Healthcare, Agilent Technologies, Bio-Rad Laboratories, Promega Corporation, Cell Biolabs, PerkinElmer, Miltenyi Biotec, HemoGenix, Bio-Techne Corporation, STEMCELL Technologies, and Cellular Dynamics International.

We Do Offer Sample of this report. Kindly go through the follow information in order to access the report.

Note- This report sample includes:

Brief Introduction to the research report.

Table of Contents (Scope covered as a part of the study)

Top players in the market

Research framework (Structure Of The Report)

Research methodology adopted by Coherent Market Insights

Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/1632

The report begins with a brief introduction and market overview of the Stem Cell Assay industry followed by its market scope and size. Next, the report provides an overview of market segmentation such as type, application, and region. The drivers, limitations, and opportunities for the market are also listed along with current trends and policies in the industry.

The key players profiled in this report include: Merck & Co., Thermo Fisher Scientific, GE Healthcare, Agilent Technologies, Bio-Rad Laboratories, Promega Corporation, Cell Biolabs, PerkinElmer, Miltenyi Biotec, HemoGenix, Bio-Techne Corporation, STEMCELL Technologies, and Cellular Dynamics International.

Regions included:

o North America (United States, Canada, and Mexico)

o Europe (Germany, France, UK, Russia, and Italy)

o Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

o South America (Brazil, Argentina, Colombia)

o Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

The PDF Research only provides Table of Contents (ToC), scope of the report and research framework of the report.

Get a PDF Brochure of this Report: https://www.coherentmarketinsights.com/insight/request-pdf/1632

Key Benefits:

o This study gives a detailed analysis of drivers and factors limiting the market expansion of Stem Cell Assay

o The micro-level analysis is conducted based on its product types, end-user applications, and geographies

o Porters five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players

o By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Stem Cell Assay market

The research study can answer the following Key questions:

Table of Contents

Report Overview: It includes the Stem Cell Assay market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary: This section of the report gives information about Stem Cell Assay market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

Profiles of International Players: Here, key players of the Stem Cell Assay market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

Regional Study: All of the regions and countries analyzed in the Stem Cell Assay market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Get Offer on Report: https://www.coherentmarketinsights.com/insight/request-discount/1632

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, LATAM, West Europe, MENA Countries, Southeast Asia or Asia Pacific.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us: Coherent Market Insights, 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Email: sales@coherentmarketinsights.com Phone: US +1-206-701-6702/UK +44-020 8133 4027

See the rest here:
Impact of COVID-19 on Stem Cell Assay Market To Experience Significant Growth During The Forecast Period 2020-2027 | By Top Key Players Merck &...

Animal Stem Cell Therapy Market What Factors will drive the Animal Stem Cell Therapy Market in Upcoming Years and How it is Going to Impact on Global…

This report on the global Animal Stem Cell Therapy market gives a thorough study that is primarily focused on top players and their business stratagem, geographical extent, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is explicitly prepared to explore crucial fragments of the global Animal Stem Cell Therapy market. For instance, the market dynamics section in the report gives an in-depth analysis of the drivers, restraints, trends, and opportunities in the global Animal Stem Cell Therapy market. With both qualitative and quantitative analysis, we provide you with thorough and comprehensive information on the global Animal Stem Cell Therapy market. The study also entails SWOT, PESTLE, and Porters Five Forces analyses of the global Animal Stem Cell Therapy market.

This is the most recent report inclusive of the COVID-19 effects on the functioning of the market. It is well known that some changes, for the worse, were administered by the pandemic on all industries. The current scenario of the business sector and pandemics impact on the past and future of the industry are covered in this report.

Interested in this Animal Stem Cell Therapy market report? Get your FREE sample now! https://www.marketographics.com/sample-enquiry-form/4606

Global Animal Stem Cell Therapy market competition by top manufacturers/players, with Animal Stem Cell Therapy sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including:

VETSTEM BIOPHARMA MediVet Biologic J-ARM Celavet Magellan Stem Cells U.S. Stem Cell Cells Power Japan ANIMAL CELL THERAPIES Animal Care Stem Cell Therapy Sciences VetCell Therapeutics Animacel Aratana Therapeutics

The report is collated with the help of advanced tools and the recent primary and secondary research methodologies. Our expert analysts gather information and data available in the annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases. In order to ensure the authenticity of the information and data studied in this report, our researchers undertake paid primary interviews with industry experts alongside other relevant entities associated with the global Animal Stem Cell Therapy market.

By Type

Dogs Horses Others

By Application

Veterinary Hospitals Research Organizations

!!! Limited Time DISCOUNT Available!!! Get Your Copy at Discounted [emailprotected] https://www.marketographics.com/discount-enquiry-form/4606

Market segment by Region/Country including:

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Spain etc.)

Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

South America Brazil, Argentina, Colombia and Chile etc.)

Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

Objective of Studies:

If you have any special requirement, please let us know and we can provide you the report as your requirement.

#Animal Stem Cell Therapy Market Report to grow your business needs and avail 15% FREE customization on the [emailprotected] https://www.marketographics.com/request-customization-form/4606

To a producer, can control the total production cost through worldwide procurement, localization procurement and concentrative purchase, more purchasing focuses on fewer suppliers to large-scale purchase, to large-scale and high efficiency. Now the logistics and information is well-developed, beneficial to worldwide procurement, localization procurement and concentrative purchase. In future, more manufacturers will attach importance to the raw materials purchasing, with strategic sourcing.

Here are the questions we answer

Browse complete Animal Stem Cell Therapy report description And Full TOC @ https://www.marketographics.com/industry-reports/animal-stem-cell-therapy-market

To summarize, the global Animal Stem Cell Therapy market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:With reports from over 500 prominent publishers as well as daily updates on our collection, intended to empower companies and individuals catch-up with vital insights on industries operating across different geographies, along with the trends, share, size and growth rate of market verticals and numerous other services, we have our fingers dipped in just about everything market research-related. Besides meticulously curated research reports, our clients can also access our specialized services without any additional charges to gain vital market insights.

Contact Us: John Watson Head of Business Development Office No, 203 Chandan Nagar, Kharadi Pune, Maharashtra 411014 Direct Line:+918484002482 Visit our News Site: http://newssucceed.com

Visit link:
Animal Stem Cell Therapy Market What Factors will drive the Animal Stem Cell Therapy Market in Upcoming Years and How it is Going to Impact on Global...

What are the 3D Cell Culture Market Key Insights and COVID-19 Business Impact? – 3rd Watch News

Post COVID-19 Impact on 3D Cell Culture Market

With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues. Research Dive group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive study by our qualified team of experts.

Our study helps to acquire the following: Long-term and short-term impact of Covid-19 on the market Cascading impact of Covid-19 on 3D Cell Culture Market, due to the impact on its extended ecosystem Understanding the market behavior Pre- and Post-COVID-19 pandemic Strategy suggestions to overcome the negative impact or turn the positive impact into an opportunity Well help you fight this crisis through our business intelligence solutions.

Connect with Analyst to Reveal How COVID-19 Impacting On 3D Cell Culture Market: https://www.researchdive.com/connect-to-analyst/73

Pre COVID-19 Analysis of 3D Cell Culture Market

According to a study of Research Dive, global 3D Cell Culture market forecast shall cross $12,638.8 million by 2026, growing at a CAGR of 29.4 during forecast period.

3D Cell culture is an essential tool in clinical analysis and biological science. It has multiple applications such as in biosensors, drug screening and others. Many improvements have been made in automated high-throughput cell culture systems. Increasing demand for regenerative medicine and economic drug discovery is expected to drive the demand for the 3D cell culture market. 3D cell cultures are primarily used to observe the abnormal behavior of cells and the cell-cell interaction. Furthermore, 3D cell culture systems play a significant role in the development of precision medicine and personalized medicine. For instance, as per study of cancer researchers (University of Michigan) newly invented 3D structure could enable physicians to test medications on model tumors grown from a patients own cells. These advances are projected to boost the growth of global cell culture market. However, more complex culture system, added expenses and threats from substitutes like 2D cell cultures are projected to limit the 3D cell culture market growth.

With new advances, 3D composite scaffolds have many versatile properties. It will be tremendously useful to develop treatments for nerve disorders and spinal cord injury (SCI) by taking help of cell transplantation methodologies and biomaterials. The most remarkable advantage of 3D cell culture is, their properties can be easily adapted by modifying the structure and composition. These key factors of 3D cell culture are projected to create enormous opportunities for the growth of 3D cell culture industry.

According to Analyst Evaluation, Microchips market shall register a revenue of $2,515.5 million by the end of 2026, growing at a CAGR of 30.1% during the forecast period; this is significantly due to new advances in 3D culture organs-on-chips. Organs-on-chips allow study of human physiology and also reveal development of novel in vitro disease models. It could provide potential replacements for animals used in toxin testing and drug development. These advancements are anticipated to grow the demand of microchips in global market, and are projected to boost the global market. Scaffold-based platforms have the largest market share and this segment will register a revenue of $3,425.1 million by the end of 2026, growing at a CAGR of 28.4%. Scaffolds can be significantly used in drug development therapeutic or specialty areas; which is anticipated to fuel the of global market growth.

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/download-sample/73

Based on applications, the market is segmented into Stem Cell research, drug discovery, cancer research, and regenerative medicine. 3D cell culture market size for cancer research will generate a revenue of $4,057.1 million by 2026, growing at a CAGR of 28.5% throughout the forecast period; this is majorly due to various types of cancers such as breast cancer, lung cancer and others being dominant among the population. Cancer has a pervasive prevalence across the globe, which has led to rise in demand for cancer research, which is further attributed to boost the demand for 3D cell culture market. 3D cell culture market for regenerative medicine will register a revenue of $3,690.5 million by 2026, growing at a CAGR of 30.1%. Many developed and developing countries such as Japan is focusing more on contract manufacturing tie-ups, and continues to be a lucrative place for biotech ventures to do business. Japan is the world leader in regenerative medical products; these key strategies of the government are anticipated to spur the growth of 3D cell culture market.

3D cell culture market for biotechnology & pharmaceutical companies will register a revenue of $5,184.4 million by 2026, growing at a CAGR of 28.9% during the forecast period; this is majorly due to huge developments in the laboratory, technology and operations. Furthermore, rising pressure on sales of established treatments, rapid growth of cell therapies and focus on advanced manufacturing and technologies are the factors expected to grow the market.

North America 3D Cell Culture market size will cross $4,019.1 million by 2026, increasing at a healthy CAGR of 28.1%.

Heavy investments in research & development, high healthcare expenditure, and extensively increasing number of cancer cases are considered to be one of the driving factors that are booming the growth of North American market.

3D Cell Culture market share for Asia-Pacific region is expected to rise at a CAGR of 30.7% by generating a revenue of $3,020.7 million by 2026. The market growth in the region is increasing drug discovery initiatives among pharmaceuticals and biotechnology companies in the region. Major economies such as India, Singapore, Japan and South Korea are emphasizing more on public sector openness to partnership with established companies. For instance, leading market players such as Bayer, GlaxoSmithKline and AstraZeneca are collaborating with Singapore partners across drug discovery.

View out Trending Reports with the Impact of COVID-19: https://www.researchdive.com/covid-19-insights

The major 3D Cell Culture manufacturers include QGel SA, Hrel Corporation, SynVivo, Greiner Bio-One International, Advanced BioMatrix, Lonza, Corning Incorporated, Thermo Fisher Scientific, TissUse GmbH, 3D Biotek. Players using updated technologies for their 3D Cell Culture will have good probability of having success in the rapidly blooming market. For example, Lonza has innovated the RAFT 3D Culture System that produces hepatocytes with increased stability and stronger cytochrome responses.

Contact Us:

Mr. Abhishek Paliwal Research Dive 30 Wall St. 8th Floor, New York NY 10005 (P) + 91 (788) 802-9103 (India) +1 (917) 444-1262 (US) Toll Free : +1 -888-961-4454 Email:[emailprotected] LinkedIn:https://www.linkedin.com/company/research-dive Twitter:https://twitter.com/ResearchDive Facebook:https://www.facebook.com/Research-Dive Blog:https://www.researchdive.com/blog Follow us on:https://covid-19-market-insights.blogspot.com

Read more:
What are the 3D Cell Culture Market Key Insights and COVID-19 Business Impact? - 3rd Watch News

Explosive Growth of IVIS Imaging Systems Market By 2027 Competitive Outlook By PerkinElmer Inc., Hallmarq Veterinary Imaging, CANON MEDICAL SYSTEMS…

Increasing prevalence of chronic diseases, aging population and demand of high resolution diagnostic methods are prime drivers for the market. Increasing cancer, cardiovascular, respiratory and other life threatening conditions in the developing countries are increasing demand for IVIS system in the forecast period. Moreover, increased research activities worldwide are creating lucrative opportunities for the market.

Leading IVIS Imaging Systems Market Players:

PerkinElmer Inc., Hallmarq Veterinary Imaging, CANON MEDICAL SYSTEMS CORPORATION, IDEXX, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., ISHIDA CO.,LTD, FUJIFILM Holdings Corporation, Bruker Corporation, IMPERIAL LIFE SCIENCES (P) LIMITED

Get Sample Copy of this Report at: https://www.reportsweb.com/inquiry&RW00013350526/sample

The IVIS imaging system is noninvasive technique to monitor cell trafficking, gene expression, and disease progression. These are used in a variety of applications including oncology, infectious disease, musculoskeletal, cardiovascular, neurology, respiratory and stem cell research.

The Global IVIS Imaging Systems Market Analysis to 2027 is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of IVIS Imaging Systems market with detailed market segmentation by type, end user, and geography. The global IVIS Imaging Systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading IVIS Imaging Systems market players and offers key trends and opportunities in the market.

Get Discount for This Report @ https://www.reportsweb.com/inquiry&RW00013350526/discount

The report covers key developments in the IVIS imaging systems market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from IVIS Imaging Systems market are anticipated to lucrative growth opportunities in the future with the rising demand for IVIS Imaging Systems market in the global market. Below mentioned is the list of few companies engaged in the IVIS Imaging Systems market.

Reason to Buy

Inquire for Report buying @ https://www.reportsweb.com/inquiry&RW00013350526/buying

Table of Content:

Market Overview

Competition Analysis by Players

Company (Top Players) Profiles

IVIS Imaging Systems Market Size by Type and Application

US Market Status and Outlook

EU Development Market Status and Outlook

Japan Market Development Status and Outlook

China Market Status and Outlook

India IVIS Imaging Systems Market Status and Outlook

Southeast Asia Market Status and Outlook

Market Forecast by Region, Type, and Application

Market Dynamics

Market Effect Factor Analysis

Research Finding/ Conclusion

Appendix

About ReportsWeb:

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us:

Call: +1-646-491-9876 Email: [emailprotected]

Here is the original post:
Explosive Growth of IVIS Imaging Systems Market By 2027 Competitive Outlook By PerkinElmer Inc., Hallmarq Veterinary Imaging, CANON MEDICAL SYSTEMS...

Global Cell Culture Market 2020 | Scope of Current and Future Industry 2025 – 3rd Watch News

This report additionally covers the effect of COVID-19 on the worldwide market. The pandemic brought about by Coronavirus (COVID-19) has influenced each part of life all inclusive, including the business segment. This has brought along a several changes in economic situations.

The Latest Research Report on Cell Culture Market size | Industry Segment by Applications, by Type, Regional Outlook, Market Demand, Latest Trends, Cell Culture Industry Share & Revenue by Manufacturers, Company Profiles, Growth Forecasts 2025. Analyzes current market size and upcoming 5 years growth of this industry.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures): http://marketresearchbazaar.com/requestSample/14980

Summary ICRWorlds Cell Culture market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players. Global Cell Culture Market: Product Segment Analysis Classical Media & Salts Serum-free Media Stem Cell Media Global Cell Culture Market: Application Segment Analysis Biopharmaceutical Manufacturing Tissue Culture & Engineering Global Cell Culture Market: Regional Segment Analysis USA Europe Japan China India South East Asia The Players mentioned in our report Life Technologies Corning (Cellgro) Thermo Fisher Merck Millipore GE Healthcare Lonza BD HiMedia Takara Sigma-Aldrich BBI

Request Customization: http://marketresearchbazaar.com/enquiry/14980

Cell Culture Market: Regional Analysis

The report offers in-depth assessment of the growth and other aspects of the Cell Culture market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2025. These analyses will help the reader to understand the potential worth of investment in a particular region.

Key Strategic Developments:The study also includes the key strategic developments of the Cell Culturemarket, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Key Market Features:The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, market share, CAGR, and gross margin. Analytical Tools: The Cell Culture Market report includes the precisely studied and weighed data of the key industry players and their scope in the Cell Culture market by means of several analytical tools

About (Market Research Bazaar):

Market Research Bazaar (MRB)- a part of VRRB Reports LLP is an overall Market Research and consulting organization. We give unparalleled nature of offering to our clients present all around the world crosswise over industry verticals. Market Research Bazaar has aptitude in giving profound jump showcase understanding alongside advertise knowledge to our clients spread across over different endeavours.

Media Contact:

Market Research Bazaar

UK: +442070973908

US: +13156360953

India: +919548234540

Email:[emailprotected]

Website:http://marketresearchbazaar.com/

Blog:http://marketresearchbazaar.com/blogs

See the article here:
Global Cell Culture Market 2020 | Scope of Current and Future Industry 2025 - 3rd Watch News

Cord Blood Banking Market 2020: Global Industry Analysis By Size, Share, Growth, Trends And Forecast To 2026 – Cole of Duty

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Cord Blood Banking market.

Trusted Business Insights presents an updated and Latest Study on Cord Blood Banking Market 2019-2026. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Cord Blood Banking market during the forecast period (2019-2029). It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Cord Blood Banking Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19)

Abstract, Snapshot, Market Analysis & Market Definition: Cord Blood Banking Market Industry / Sector Trends

Cord Blood Banking Market size was valued over USD 16 billion in 2018 and is expected to witness more than 5% CAGR from 2019 to 2025.

U.S. cord blood banking market, by type of bank, 2018 & 2025 (USD Million)

Growing prevalence of genetic disorders such as sickle cell anemia, thalassemia, cystic fibrosis, Tay-Sachs disease, haemophilia, fragile X syndrome and Huntingtons disease are the primary factor for the growth of cord blood banking market. As per the WHO estimates, about 2 million people in the U.S. are estimated to carry sickle cell allele. Growing burden of genetic disorders will drive the demand for cord blood transplantations in the future, thus fostering business growth.

Increasing awareness pertaining to various therapeutic applications of cord blood cells will serve as high impact rendering factor. Numerous government and private organizations are involved in creating awareness regarding numerous advantages of preservation of cord blood. For instance, In April 2015, BioInformant Worldwide partnered with Save the Cord Foundation to launch cord blood banking awareness campaign with an aim to educate expecting parents about the medical benefits of cord blood preservation. Aforementioned factors will be conducive to industry growth.

Market Segmentation, Outlook & Regional Insights: Cord Blood Banking Market

Cord Blood Banking Market, By Type of Bank

Germany cord blood banking market share, by type of bank, 2018

Private cord blood banks held majority share of the total market, accounting for revenue of USD 13.7 billion in 2018. Growing awareness among expectant parents as well as high demand to safeguard the health of family members by storing and preserving precious cord blood stem cells will drive the private cord blood banking market. Factors such as sufficient supply of cord blood along with guarantee for the availability of cells for transplantation in multiple relatives further will boost segmental growth.

Public cord blood banks are forecasted to expand at a CAGR of 6.1% from 2019 to 2025. Factors such as increase in the number and diversity of cord blood units available for patients and strong support from the federal and private funding will propel the demand for public cord blood banking, hence enhancing the segmental growth. Moreover, public banks are the primary source of cord blood cells for research professionals to investigate novel and potentially life-saving therapies for the patient population, thus propelling segment growth.

Cord Blood Banking Market, By Services

Processing service market segment accounted for USD 12.6 billion in 2018 and is expected to dominate the industry during the forecast timeframe. High growth is attributed to various technological advancements in cord blood processing methods. For instance, PrepaCyte-CB is a premium processing method of Cryo-Cell that provides better separation along with less crossover of the red and white cells. Contamination of red blood cells can be toxic and may lead to loss of precious cord blood cells during freezing. Removal of RBCs require processing, thus leading to segmental growth during the forecast period.

Storage service market segment will grow rapidly at 5.6% during the forecast timeframe. High growth is attributed to increasing number of expectant parents availing preservation of the new-borns cord blood cells. Additionally, various offers and discounts gives by private cord blood banks for long-term storage of cord blood cells of infants will significantly drive the storage services in the future.

Cord Blood Banking Market, By Application

Immuno-deficiency disorders is expected to grow at 5.6% in the upcoming years. Cord blood cells are increasingly being used for the treatment of primary immuno-deficiency disorders. Factors such as rapid and reliable recovery of immune function, low risk of graft versus host disease, and low viral transmission rate will boost the growth of the market for immuno-deficiency disorders treatment. In addition, government organizations are constantly providing funds along with spreading awareness related to stem cell transplants thus propelling segment growth.

Metabolic disorders segment accounted for USD 1.9 billion in 2018. Rising incidence of various metabolic disorders such as Krabbe leukodystrophy, Gunther Disease, Tay-Sachs disease will boost the application of cord blood cells for treatment of metabolic disorders. Cord blood cells are less reactive and more adaptable once they enter the patients body. Cord blood stem cell transplantation is the only effective treatment for the ailment in mildly affected late-onset patients and pre-symptomatic infantile patients, hence expanding the segment growth during the forecast timeframe.

Cord Blood Banking Market, By End-use

Hospitals segment accounted for revenue of USD 9.4 billion in 2018. Hospitals have a complete transplantation set up with latest technology and a highly experienced and qualified healthcare personnel. Furthermore, advancements in the field of cord blood banking and its growing popularity will consequently increase the application of cord blood transplantations in the near future. Increasing prevalence of genetic diseases and cancer around the globe is driving the hospitals market for cord blood treatment.

Specialty clinics segment held market share of 21.9% in 2018. Specialty clinics segment will have moderate growth rate due to increasing technological advancements that improve the quality of treatment related to cord blood transplantations. Major public and private banks facilitate cord blood units that are successfully used in the treatment of various form of cancer and genetic diseases, hence enhancing the segmental growth.

Cord Blood Banking Market, By Region

North America cord blood banking market share, by country, 2025 (USD Million)

North American market is expected to reach USD 6.9 billion by 2025. High growth rate is attributed to presence of large number of players operating in the country, thus augmenting market growth. Additionally, presence of large number of genetic disorders will further fuel the demand for cord blood cells market. Moreover, continuous efforts by researchers to explore new therapeutic applications of cord blood cells will spur market growth.

Asia Pacific cord blood banking market is forecasted to show growth of 6.7% from 2019 to 2025. High growth is attributable to increasing awareness regarding the advantages of preservation of cord blood cells across the developing economies of India and China. Additionally, these countries have great potential for growth due to comparatively higher birth rate. Furthermore, various market players are entering the developing nations to explore untapped opportunities, thus fostering business growth in the region.

Key Players, Recent Developments & Sector Viewpoints: Cord Blood Banking Market

Key industry players in global cord blood banking market are Singapore Cord Blood Bank, CBR Systems, ViaCord LLC, Cordlife, FamiCord, Cryo-Save, Americord, Global Cord Blood Corporation, LifeCell and Jeevan Stem Cell Foundation. Various strategies such as collaborations, acquisitions, mergers are undertaken by these players to strengthen market position.

Recent industry developments:

In April 2019, FamiCord Group announced the agreement of future business cooperation with CelluGen Biotech (India). This agreement will assist to generate beneficial synergies for both the companies in the field of family-based stem cell banking and the development of new stem cell-based drugs

In September 2018, CryoSave announced the introduction of its new storage facility in Geneva. This new safe and secure sample storage BioBank in its state-of-the-art central laboratory ensures a capacity of cryopreservation for more than millions of samples thus, increasing its storage facilities.

Cord Blood Banking Industry Viewpoint

Cord blood transplant can be traced back to the early 1990s when the first cord blood transplant was performed for treating T?cell leukemia. Since then, the technique underwent numerous advancements due to extensive R&D activities to explore new therapeutic implications. Currently cord blood is used for more than 80 therapeutic applications ranging from genetic disorders to metabolic disorders. In 2005, National Cord Blood Inventory (NCBI) was formed with the aim to increase the national supply of publicly donated cord blood units. Cord blood banking industry is expected to grow swiftly in the developing economies such as India and China due to high birth rate and growing healthcare infrastructure. Major market players are exploring the untapped opportunities to increase their market presence that will further boost cord blood banking industry.

Key Insights Covered: Exhaustive Cord Blood Banking Market 1. Market size (sales, revenue and growth rate) of Cord Blood Banking industry. 2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Cord Blood Banking industry. 3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Cord Blood Banking industry. 4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Cord Blood Banking industry.

Research Methodology: Cord Blood Banking Market

Quick Read Table of Contents of this Report @ Cord Blood Banking Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19)

Trusted Business Insights Shelly Arnold Media & Marketing Executive Email Me For Any Clarifications Connect on LinkedIn Click to follow Trusted Business Insights LinkedIn for Market Data and Updates. US: +1 646 568 9797 UK: +44 330 808 0580

Read the rest here:
Cord Blood Banking Market 2020: Global Industry Analysis By Size, Share, Growth, Trends And Forecast To 2026 - Cole of Duty

Capillary Electrophoresis Market Projection By Key Players, Status, Growth, Revenue, SWOT Analysis Forecast 2026 – 3rd Watch News

The Capillary Electrophoresis market report added recently by Analytical Research Cognizance, evaluates the industry in terms of market size, market share, revenue estimation, and geographical outlook. The study also delivers a precise summary that illustrates the competitive milieu, growth opportunities and application landscape of the Capillary Electrophoresis market depending on the industrys financial and non-financial impact.

The Capillary Electrophoresis market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Capillary Electrophoresis market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porters Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Capillary Electrophoresis market.

Download PDF Sample of Capillary Electrophoresis Market report @ https://www.arcognizance.com/enquiry-sample/941957

Major Players in the global Capillary Electrophoresis market include: Affymetrix, Inc. (US) Sartorius Stedim Biotech SA (France) A Becton, Dickinson and Company (US) Agilent Technologies, Inc. (US) Alfa Laval AB (Sweden) AB Sciex (US) 3M Purification, Inc. (US) GE Healthcare (UK) PerkinElmer, Inc. (US) Merck KGaA (Germany)

On the basis of types, the Capillary Electrophoresis market is primarily split into: Type 1 Type 2 Type 3

On the basis of applications, the market covers: Versatile Use Clinical Applications Research Applications Drug Discovery Biomedical Research Fetal Cell Separation Stem Cell Sorting Marine Biology and Environmental Sciences Microbiology

Brief about Capillary Electrophoresis Market Report with [emailprotected] https://www.arcognizance.com/report/global-capillary-electrophoresis-market-report-2019-competitive-landscape-trends-and-opportunities

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions: United States Europe (Germany, UK, France, Italy, Spain, Russia, Poland) China Japan India Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam) Central and South America (Brazil, Mexico, Colombia) Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria) Other Regions

Chapter 1 provides an overview of Capillary Electrophoresis market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Capillary Electrophoresis market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Capillary Electrophoresis industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Capillary Electrophoresis market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Capillary Electrophoresis, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Capillary Electrophoresis in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Capillary Electrophoresis in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Capillary Electrophoresis. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Capillary Electrophoresis market, including the global production and revenue forecast, regional forecast. It also foresees the Capillary Electrophoresis market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report: Historical Years: 2014-2018 Base Year: 2019 Estimated Year: 2019 Forecast Period: 2019-2026

Single User License Copy and Other Purchase [emailprotected] https://www.arcognizance.com/purchase/941957

Some Point of Table of Content:

Chapter One: Capillary Electrophoresis Market Overview

Chapter Two: Global Capillary Electrophoresis Market Landscape by Player

Chapter Three: Players Profiles

Chapter Four: Global Capillary Electrophoresis Production, Revenue (Value), Price Trend by Type

Chapter Five: Global Capillary Electrophoresis Market Analysis by Application

Chapter Six: Global Capillary Electrophoresis Production, Consumption, Export, Import by Region (2014-2019)

Chapter Seven: Global Capillary Electrophoresis Production, Revenue (Value) by Region (2014-2019)

Chapter Eight: Capillary Electrophoresis Manufacturing Analysis

Chapter Nine: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter Ten: Market Dynamics

Chapter Eleven: Global Capillary Electrophoresis Market Forecast (2019-2026)

Chapter Twelve: Research Findings and Conclusion

Chapter Thirteen: Appendixcontinued

To Check Discount of Capillary Electrophoresis Market @ https://www.arcognizance.com/discount/941957

List of tables List of Tables and Figures

Figure Capillary Electrophoresis Product Picture Table Global Capillary Electrophoresis Production and CAGR (%) Comparison by Type Table Profile of Type 1 Table Profile of Type 2 Table Profile of Type 3 Table Capillary Electrophoresis Consumption (Sales) Comparison by Application (2014-2026) Table Profile of Versatile Use Table Profile of Clinical Applications Table Profile of Research Applications Table Profile of Drug Discovery Table Profile of Biomedical Research Table Profile of Fetal Cell Separation Table Profile of Stem Cell Sorting Table Profile of Marine Biology and Environmental Sciences Table Profile of Microbiology Figure Global Capillary Electrophoresis Market Size (Value) and CAGR (%) (2014-2026) Figure United States Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Europe Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Germany Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure UK Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure France Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Italy Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Spain Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Russia Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Poland Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure China Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Japan Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure India Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Southeast Asia Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Malaysia Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Singapore Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Philippines Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Indonesia Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Thailand Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Vietnam Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Central and South America Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Brazil Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Mexico Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Colombia Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Middle East and Africa Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Saudi Arabia Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure United Arab Emirates Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Turkey Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Egypt Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure South Africa Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Nigeria Capillary Electrophoresis Revenue and Growth Rate (2014-2026) Figure Global Capillary Electrophoresis Production Status and Outlook (2014-2026) Table Global Capillary Electrophoresis Production by Player (2014-2019) Table Global Capillary Electrophoresis Production Share by Player (2014-2019) Figure Global Capillary Electrophoresis Production Share by Player in 2018 Table Capillary Electrophoresis Revenue by Player (2014-2019) Table Capillary Electrophoresis Revenue Market Share by Player (2014-2019) Table Capillary Electrophoresis Price by Player (2014-2019) Table Capillary Electrophoresis Manufacturing Base Distribution and Sales Area by Player Table Capillary Electrophoresis Product Type by Player Table Mergers & Acquisitions, Expansion Plans Table Affymetrix, Inc. (US) Profile Table Affymetrix, Inc. (US) Capillary Electrophoresis Production, Revenue, Price and Gross Margin (2014-2019) Table Sartorius Stedim Biotech SA (France) Profile Table Sartorius Stedim Biotech SA (France) Capillary Electrophoresis Production, Revenue, Price and Gross Margin (2014-2019) Table A Profile Table A Capillary Electrophoresis Production, Revenue, Price and Gross Margin (2014-2019) Table Becton, Dickinson and Company (US) Profile Table Becton, Dickinson and Company (US) Capillary Electrophoresis Production, Revenue, Price and Gross Margin (2014-2019) Table Agilent Technologies, Inc. (US) Profile Table Agilent Technologies, Inc. (US) Capillary Electrophoresis Production, Revenue, Price and Gross Margin (2014-2019) Table Alfa Laval AB (Sweden) Profile Table Alfa Laval AB (Sweden) Capillary Electrophoresis Production, Revenue, Price and Gross Margin (2014-2019) Table AB Sciex (US) Profile Table AB Sciex (US) Capillary Electrophoresis Production, Revenue, Price and Gross Margin (2014-2019) Table 3M Purification, Inc. (US) Profile Table 3M Purification, Inc. (US) Capillary Electrophoresis Production, Revenue, Price and Gross Margin (2014-2019) Table GE Healthcare (UK) Profile Table GE Healthcare (UK) Capillary Electrophoresis Production, Revenue, Price and Gross Margin (2014-2019) Table PerkinElmer, Inc. (US) Profile Table PerkinElmer, Inc. (US) Capillary Electrophoresis Production, Revenue, Price and Gross Margin (2014-2019) Table Merck KGaA (Germany) Profile Table Merck KGaA (Germany) Capillary Electrophoresis Production, Revenue, Price and Gross Margin (2014-2019) Table Global Capillary Electrophoresis Production by Type (2014-2019) Table Global Capillary Electrophoresis Production Market Share by Type (2014-2019) Figure Global Capillary Electrophoresis Production Market Share by Type in 2018 Table Global Capillary Electrophoresis Revenue by Type (2014-2019) Table Global Capillary Electrophoresis Revenue Market Share by Type (2014-2019) Figure Global Capillary Electrophoresis Revenue Market Share by Type in 2018 Table Capillary Electrophoresis Price by Type (2014-2019) Figure Global Capillary Electrophoresis Production Growth Rate of Type 1 (2014-2019) Figure Global Capillary Electrophoresis Production Growth Rate of Type 2 (2014-2019) Figure Global Capillary Electrophoresis Production Growth Rate of Type 3 (2014-2019) Table Global Capillary Electrophoresis Consumption by Application (2014-2019) Table Global Capillary Electrophoresis Consumption Market Share by Application (2014-2019) Table Global Capillary Electrophoresis Consumption of Versatile Use (2014-2019) Table Global Capillary Electrophoresis Consumption of Clinical Applications (2014-2019) Table Global Capillary Electrophoresis Consumption of Research Applications (2014-2019) Table Global Capillary Electrophoresis Consumption of Drug Discovery (2014-2019) Table Global Capillary Electrophoresis Consumption of Biomedical Research (2014-2019) Table Global Capillary Electrophoresis Consumption of Fetal Cell Separation (2014-2019) Table Global Capillary Electrophoresis Consumption of Stem Cell Sorting (2014-2019) Table Global Capillary Electrophoresis Consumption of Marine Biology and Environmental Sciences (2014-2019) Table Global Capillary Electrophoresis Consumption of Microbiology (2014-2019) Table Global Capillary Electrophoresis Consumption by Region (2014-2019) Table Global Capillary Electrophoresis Consumption Market Share by Region (2014-2019) Table United States Capillary Electrophoresis Production, Consumption, Export, Import (2014-2019) Table Europe Capillary Electrophoresis Production, Consumption, Export, Import (2014-2019) Table China Capillary Electrophoresis Production, Consumption, Export, Import (2014-2019) Table Japan Capillary Electrophoresis Production, Consumption, Export, Import (2014-2019) Table India Capillary Electrophoresis Production, Consumption, Export, Import (2014-2019) Table Southeast Asia Capillary Electrophoresis Production, Consumption, Export, Import (2014-2019) Table Central and South America Capillary Electrophoresis Production, Consumption, Export, Import (2014-2019)continued

If you have any special requirements, please let us know and we will offer you the report as you want.

Our trending Report Links: Global Coatings For Medical Devices Market Report 2019, Competitive Landscape, Trends and [emailprotected] https://www.marketwatch.com/press-release/coatings-for-medical-devices-market-growth-industry-trends-2020-size-by-regions-global-industry-share-sales-revenue-and-opportunities-till-2026-with-covid-19-impact-2020-05-27

Global Population Health Management Systems Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to [emailprotected] https://www.marketwatch.com/press-release/population-health-management-systems-market-share-size-type-demand-trends-analysis-growth-applications-research-emerging-technologies-opportunities-till-2024-with-covid-19-impact-2020-05-27

About Us:Analytical Research Cognizance (ARC)is a trusted hub for research reports that critically renders accurate and statistical data for your business growth. Our extensive database of examined market reports places us amongst the best industry report firms. Our professionally equipped team further strengthens ARCs potential.

ARC works with the mission of creating a platform where marketers can have access to informative, latest and well researched reports. To achieve this aim our experts tactically scrutinize every report that comes under their eye.

Contact Us: Ranjeet Dengale Director Sales Analytical Research Cognizance Office no, 201, 2nd Floor, Jachak Chambers, Pimple Saudagar, Pune 411027, Maharashtra, India +1 (646) 403-4695, +91 90967 44448 Email: [emailprotected]

Follows to Twitter : https://twitter.com/ARCognizance

Follows to Linkdin : https://www.linkedin.com/company/arcognizance

Continue reading here:
Capillary Electrophoresis Market Projection By Key Players, Status, Growth, Revenue, SWOT Analysis Forecast 2026 - 3rd Watch News

Stem cell study aims to fight the COVID-19 ‘storm’ – Cayman Compass

Residents of the Caribbean know that between a tropical storm and a major hurricane, there is a world of difference. Both bring rain and winds, but weathering and surviving a hurricane requires much greater response and resilience.

Dr. Javier Perez Fernandez, a specialist in critical care medicine and pulmonology at Baptist Health South Florida, views COVID-19 infections in a similar way. While some hospitalised patients face a tropical storm, others are battling a category five hurricane.

Through a new stem cell treatment, Perez says doctors at Baptist Health and Miami Cancer Institute hope to control the magnitude of COVID-19 storms and mitigate the viruss effects in the most severely affected patients.

As researchers worldwide work against the clock to fight the novel coronavirus, Perez views the stem cell treatment as one with potential for wide-spread adoption, including use in the Cayman Islands.

It converts this category five hurricane that you have inside into a tropical storm, Perez said, explaining that while the treatment cannot cure the virus, it may save lives.

The investigational drug, developed from sentinel or original cells attached to the umbilical cord, takes aim at another kind of storm, produced when the bodys immune system goes into overdrive.

A cytokine storm, seen in fatal COVID-19 cases, occurs when cytokine molecules are released by the body as an immune system response to fight infection. An excessive release of these molecules can result in hyperinflammation, organ failure and death.

With a stem cell injection, however, Perez says doctors have been able to control this cytokine storm and reduce COVID-19 impacts, such as respiratory distress.

As the cytokine storms really affect the lungs, mostly weve seen significant changes on oxygenation of people while we are delivering the cells, Perez said.

Weve seen very good responses on the patients that we have infused, and we have seen responses that lead to a reduction in the oxygen level [administered] by 50% of what they were using.

The studys results are still not ready to disclose, and Perez said the rate of research is contingent on the number of patients admitted to critical care units at partner facilities.

In that sense, he hopes the study will remain unfinished, due to a lack of severely ill patients.

I think the main limitation for faster development has been the lower number of patients that we have on intensive care units, he said.

The stem cell study has incorporated partners from several US universities, including Florida International University and University of South Dakota, and RESTEM, a California biotechnology company that develops treatments for degenerative and immune system disorders.

Once the treatment has gone through the full development and approval process, Perez sees Cayman as one of the locations that could benefit from its use.

Well be absolutely happy [to bring] not only that treatment but any other form of treatment, to be there for the people of Cayman, Perez said.

During the 17 June press briefing, Caymans chief medical officer Dr. John Lee mentioned another novel COVID-19 treatment, a steroid called dexamethasone, that is showing promise in the United Kingdom.

Its been shown to reduce deaths by up to a third and has already received approval for emergency use in the United Kingdom, Lee said, adding that he anticipates the drug will be approved and made available elsewhere.

The drug, developed by scientists at the University of Oxford, is the first treatment shown to aid severely ill COVID-19 patients. Similar to the stem cell treatment being studied by Baptist Health, dexamethasone treatment aims to reduce the effects of cytokine storms and mitigate the potentially deadly impact of an uncontrolled immune system response.

If you value our service, if you have turned to us in the past few days or weeks for verified, factual updates, if you have watched our live streaming of press conferences or sent an article to a friend... please consider a donation. Quality local journalism was at risk before the coronavirus crisis. It is now deeply threatened. Even a small amount can go a long way to sustaining our mission of informing the public. We need our readers financial support now more than ever.

Follow this link:
Stem cell study aims to fight the COVID-19 'storm' - Cayman Compass

Cell and gene therapy-focused OpenCell Technologies hires MilliporeSigma executive Kevin Gutshall as new CEO – Webster County Citizen

ST. LOUIS, June 18, 2020 /PRNewswire/ -- OpenCell Technologies, an R&D-stage biomedical venture, has announced the hiring of Kevin Gutshall as CEO. Kevin leaves his role as MilliporeSigma's director of life science business development and M&A focusing on the cell and gene therapy business unit, to join OpenCell and lead its efforts to translate and commercialize its core technology platform, POROS.

OpenCell was established based on technology developed at the Georgia Institute of Technology, by Engineering faculty and company co-founders Mark Meacham, PhD, Andrei Fedorov, PhD, and Levent Degertekin, PhD. Dr. Meacham was subsequently recruited to Washington University in St. Louis, and OpenCell relocated to the BioGenerator Labs in the Cortex Innovation Community adjacent to the Washington University School of Medicine. The company's core technology, which has broad applications ranging from fuel and energy to life sciences, is focused on the rapidly emerging cell and gene therapy market.

"I am thrilled to join OpenCell, as it is now poised to move from an R&D stage to a commercial business," said Gutshall. "I believe that the POROS platform will be a disruptive technology platform in the cell and gene therapy marketplace."

During its seed stage, the company benefitted from BioGenerator Entrepreneurs-in-Residence (EIR) that brought key expertise to the company as it pivoted from the research tools market to cell and gene therapy applications. Paul Olivo, MD, PhD, a former BioGenerator EIR and current Venture Partner at Synchrony Bio, which also participated in the current financing, serves as a key advisor to OpenCell, managing the company's research team. In her role as BioGenerator EIR, Heather Holeman, PhD, now CEO of Lifespan Biosciences, facilitated key business development connections for the company. Concurrent with the financing, Charlie Bolten, Senior Vice President of BioGenerator, joins OpenCell's board of directors.

"Together with Synchrony Bio, BioGenerator's investment in OpenCell is the culmination of extensive due diligence and hands-on support by our investment, Entrepreneur-in-Residence and Grants-2-Business teams," said Bolten. "With the successful recruitment of a CEO with deep experience in commercialization, business development and M&A, we are pleased to see OpenCell take an important step toward commercializing the POROS platform."

"I am excited to welcome Kevin as the new CEO of OpenCell," added Chad Stiening, OpenCell Executive Chairman and Managing Director at Synchrony Bio. "His professional background and personal passion in the cell and gene therapy space is a perfect fit for the company as it seeks to realize the full potential of its technology and enable the development and manufacturing of promising new therapies in this dynamic market."

In addition to investments from BioGenerator and Synchrony Bio, the company has leveraged significant Federal grant funding over $3M total to help secure equity financing and achieve key milestones that helped attract strategic partnering interest as well as its new CEO.

About OpenCellOpenCell Technologies provides efficient, high-throughput and scalable transfection tools to the Life Science Industry, enabling it to use difficult-to-transfect cells (e.g., primary and cancer stem cell cultures) in development of cell-based analysis techniques and discovery of new therapeutic cell-based therapies. Unlike currently available products, the OpenCell technology features precise control of biophysical actions on a single-cell basis without sacrificing throughput. OpenCell's vision is to realize a novel, cost-effective approach to transfection that will overcome existing research and development obstacles.Our mission is to make cellular therapies effective, affordable and scalable for the clinical and research communities. Visit opencelltech.com for more information.

About BioGenerator BioGenerator, the investment arm of BioSTL, produces a sustained pipeline of successful bioscience companies and entrepreneurs in St.Louis by creating, growing and investing in promising new enterprises. Visit biogenerator.org for additional information, and follow us on LinkedIn and Twitter.

About Synchrony BioSynchrony Bio seeks to achieve consistently superior investor returns in early-stage biomedical and life science ventures by aligning seasoned talent, staged investment capital, and process efficiencies.Careful and coordinated alignment of all three is key to overcoming unique challenges faced by medical device and diagnostics ventures, in order to realize significant upside and superior returns.Synchrony's extended network of experts and advisors includes professionals with deep, cross-functional experience and backgrounds. Visit synchronybio.com for additional information.

Go here to read the rest:
Cell and gene therapy-focused OpenCell Technologies hires MilliporeSigma executive Kevin Gutshall as new CEO - Webster County Citizen